• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 1044-1058 of 1,592 results

1011 Exhibit: Ex1011 Semeraro

Document IPR2021-00881, No. 1011-11 Exhibit - Ex1011 Semeraro (P.T.A.B. May. 5, 2021)

cite Cite Document
Analyze

1179 Exhibit: Declaration of Brigid M Morris ISO Motion for Pro Hac Vice Admission

Document IPR2021-00881, No. 1179-484 Exhibit - Declaration of Brigid M Morris ISO Motion for Pro Hac Vice Admission (P.T.A.B. May. 31, 2022)

cite Cite Document
Analyze

1067 Exhibit: Ex1067 Bayer 28 April 2008

Document IPR2021-00881, No. 1067-67 Exhibit - Ex1067 Bayer 28 April 2008 (P.T.A.B. May. 5, 2021)

cite Cite Document
Analyze

2088 Exhibit: Barbazetto 2010

Document IPR2021-00881, No. 2088-191 Exhibit - Barbazetto 2010 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2100 Exhibit: Heier 2005

Document IPR2021-00881, No. 2100-203 Exhibit - Heier 2005 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2099 Exhibit: FDA 22 Case Studies

Document IPR2021-00881, No. 2099-202 Exhibit - FDA 22 Case Studies (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2132 Exhibit: Albini Deposition Exhibit 14

Document IPR2021-00881, No. 2132-235 Exhibit - Albini Deposition Exhibit 14 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2261 Exhibit: ScienceDaily FDA Approves First Angiogenesis Inhibitor

Document IPR2021-00881, No. 2261-376 Exhibit - ScienceDaily FDA Approves First Angiogenesis Inhibitor (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2221 Exhibit: Mayo Clinic Wet macular degeneration Diagnosis and treatment

Document IPR2021-00881, No. 2221-334 Exhibit - Mayo Clinic Wet macular degeneration Diagnosis and treatment (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2094 Exhibit: Brown 2011

Document IPR2021-00881, No. 2094-197 Exhibit - Brown 2011 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2097 Exhibit: FDA Non Inferiority Clinical Trials

Document IPR2021-00881, No. 2097-200 Exhibit - FDA Non Inferiority Clinical Trials (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2195 Exhibit: FocusVision Survey Sample Size How Much Do I Need

Document IPR2021-00881, No. 2195-305 Exhibit - FocusVision Survey Sample Size How Much Do I Need (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2091 Exhibit: Lucentis Label 2006

Document IPR2021-00881, No. 2091-194 Exhibit - Lucentis Label 2006 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2220 Exhibit: Manning 2015

Document IPR2021-00881, No. 2220-333 Exhibit - Manning 2015 (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze

2207 Exhibit: IQVIA Available IQVIA Data

Document IPR2021-00881, No. 2207-319 Exhibit - IQVIA Available IQVIA Data (P.T.A.B. Feb. 11, 2022)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 70 71 72 73 74 ... >>